SKAN Group AG
SIX:SKAN

Watchlist Manager
SKAN Group AG Logo
SKAN Group AG
SIX:SKAN
Watchlist
Price: 74 CHF -0.8%
Market Cap: 1.7B CHF
Have any thoughts about
SKAN Group AG?
Write Note

SKAN Group AG
Other Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

SKAN Group AG
Other Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
SKAN Group AG
SIX:SKAN
Other Current Assets
CHf17.8m
CAGR 3-Years
-13%
CAGR 5-Years
384%
CAGR 10-Years
N/A
Bachem Holding AG
SIX:BANB
Other Current Assets
CHf22.1m
CAGR 3-Years
72%
CAGR 5-Years
51%
CAGR 10-Years
26%
Siegfried Holding AG
SIX:SFZN
Other Current Assets
CHf73.1m
CAGR 3-Years
19%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Lonza Group AG
SIX:LONN
Other Current Assets
CHf236m
CAGR 3-Years
-63%
CAGR 5-Years
-38%
CAGR 10-Years
-18%
Tecan Group AG
SIX:TECN
Other Current Assets
CHf15.9m
CAGR 3-Years
-64%
CAGR 5-Years
20%
CAGR 10-Years
N/A
PolyPeptide Group AG
SIX:PPGN
Other Current Assets
€6.4m
CAGR 3-Years
25%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
No Stocks Found

SKAN Group AG
Glance View

Market Cap
1.7B CHF
Industry
Life Sciences Tools & Services

SKAN Group AG engages in the development, design, and manufacture of process isolators for the aseptic filling of biopharmaceutical products. The company is headquartered in Allschwil, Basel-Landschaft. The company went IPO on 2007-04-05. The company concentrates on companies from the industry, micro and medical technology, processing and material technology, information technology and related services. Target enterprises are those being in special situations, such as management buy-out and buy-in, changes in shareholders’ structure, succession financing, as well as coming through growth or expansion phase. The firm acts as an entrepreneurial partner in the long term. Operational activities are delegated to the independent advisor BV Partners AG. BV Holding AG and BV Partners AG form the BVgroup. As of December 31, 2011, its investment portfolio included nine companies: Covalys BioSciences AG, E2E Technologies Ltd., Lonstroff Holding AG, Piexon AG, POLYDATA AG, SKAN Holding AG, Sphinx Werkzeuge AG, Ypsomed Holding AG and Ziemer Group AG.

SKAN Intrinsic Value
93.59 CHF
Undervaluation 21%
Intrinsic Value
Price

See Also

What is SKAN Group AG's Other Current Assets?
Other Current Assets
17.8m CHF

Based on the financial report for Dec 31, 2023, SKAN Group AG's Other Current Assets amounts to 17.8m CHF.

What is SKAN Group AG's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
384%

Over the last year, the Other Current Assets growth was 19%. The average annual Other Current Assets growth rates for SKAN Group AG have been -13% over the past three years , 384% over the past five years .

Back to Top